FMS

Fresenius Medical Care AG & Co. KGaA

Stock NYSE – Stock Market Prices, News & Analysis

Fresenius Medical Care is a global provider of dialysis products and services for patients with chronic kidney failure.

$ 23.60
1.67 %

Fresenius Medical Care AG & Co. KGaA

$ 23.60
1.67 %
FMS

Fresenius Medical Care is a global provider of dialysis products and services for patients with chronic kidney failure.

Price history of Fresenius Medical Care AG & Co. KGaA
Price history of Fresenius Medical Care AG & Co. KGaA

Performance & Momentum

6 Months 13.58 %
1 Year 6.67 %
3 Years 14.12 %
5 Years 29.28 %

Strategic Analysis

Fresenius Medical Care AG & Co. KGaA • 2026

Fresenius Medical Care positions itself as a key global player in dialysis solutions, relying on an integrated model that combines medical equipment and specialized services. Its niche is in the care of patients with chronic kidney failure, with recognized expertise and a strong presence in Germany and internationally.

Strengths
  • Global leadership in the dialysis products and services market
  • Integrated business model combining materials and care, creating barriers to entry
  • Stable client portfolio in a non-cyclical sector supported by increasing medical demand
Weaknesses
  • Volatile stock performance in the medium and long term, marked by significant declines
  • Dependence on regulatory developments and medical reimbursement policies
Momentum

The momentum shows a moderate to low dynamic, reflecting a recent downward trend over the last six months despite some resilience over the past year. This configuration advises caution for investors, favoring a careful approach to sector recovery and regulatory developments.

Similar stocks to Fresenius Medical Care AG & Co. KGaA

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone